Table 1.
Antibiotic susceptibilities and phage γ sensitivities of B. anthracis strains from Cameroon
| Strain | Origin, section of Cameroona | γ Phage | MIC(s) (μg/ml) ofb: |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GEN | AMI | STR | ERY | CLI | Q-D | TET | CHL | ENR | CEP | VAN | LNZ | PEN | AMC | NIT | SXT | |||
| JF3959 | Makari, NE (GI/D3405) | Sensitive | ≤2 | ≤16 | ≤4 | 1 | ≤0.5 | 1 | ≤1 | ≤4 | ≤0.25 | ≤2 | 2 | 1 | ≤0.12 | ≤2, 1 | ≤16 | 1, 19 |
| JF3960 | Garoua, N (D4863) | Sensitive | ≤2 | ≤16 | ≤4 | 0.5 | ≤0.5 | 1 | ≤1 | ≤4 | ≤0.25 | ≤2 | ≤1 | 1 | ≤0.12 | ≤2, 1 | ≤16 | ≤0.5, 9.5 |
| JF3961 | Maloum, N (FED:77) | Sensitive | ≤2 | ≤16 | ≤4 | 0.5 | ≤0.5 | 2 | ≤1 | ≤4 | ≤0.25 | ≤2 | 2 | 1 | ≤0.12 | ≤2, 1 | ≤16 | 2, 38 |
| JF3963 | Padarmé, N (No141) | Sensitive | ≤2 | ≤16 | ≤4 | 0.5 | ≤0.5 | 2 | ≤1 | ≤4 | ≤0.25 | ≤2 | 2 | 1 | ≤0.12 | ≤2, 1 | ≤16 | 2, 38 |
| JF3964 | Koza, NE (No142) | Resistant | ≤2 | ≤16 | ≤4 | 0.5 | 1 | 2 | ≤1 | ≤4 | ≤0.25 | 8 | 2 | 2 | 8 | ≤2, 1 | ≤16 | 1, 19 |
| JF3965 | Boklé, N (D5594) | Sensitive | ≤2 | ≤16 | ≤4 | 1 | ≤0.5 | 1 | ≤1 | ≤4 | ≤0.25 | ≤2 | 2 | 1 | ≤0.12 | ≤2, 1 | ≤16 | 1, 19 |
| JF3966 | Makari, NE (Makari) | Sensitive | ≤2 | ≤16 | ≤4 | 1 | ≤0.5 | 1 | ≤1 | ≤4 | ≤0.25 | ≤2 | 2 | 1 | ≤0.12 | ≤2, 1 | ≤16 | 2, 38 |
a
Geographical origin (original strain number). N, north; E, east; NE, northeast.
b
AMI, amikacin; AMC, amoxicillin-clavulanic acid (ratio, 2:1); CEP, cephalothin; CHL, chloramphenicol; CLI, clindamycin; ENR, enrofloxacin; ERY, erythromycin; GEN, gentamicin; LZD, linezolid; NIT, nitrofurantoin; PEN, penicillin; STR, streptomycin; SXT, trimethoprim-sulfamethoxazole (ratio, 1:19); Q-D, quinupristin-dalfopristin; TET, tetracycline; VAN, vancomycin.